Table 2.

CXCR4-targeted PET imaging of patients with recurrent breast cancer with corresponding clinical data

Patient #	Age	Type	Grade	SUVmax	T/B ratio	Visible
14	62	Nodal recurrence	G2	4.2	4.7	+
15	67	Nodal recurrence	G3	4.0	3.9	+
16	64	Hepatic recurrence	G3	3.8	2.8	+
17	71	Unknown primary	G2	4.5	3.3	+
18	71	Nodal recurrence	G2	2.0	1.5	+

All metastatic lesions were visually detectable on ⁶⁸Ga-Pentixafor PET images